Kris Clark
Company: Grey Wolf Therapeutics
Job title: Head of Biology
Seminars:
Roundtable Discussion: Novel Targets for Cell Engagers & Autoimmune Disease 1:30 pm
Identifying novel targets beyond CD3, including tissue-specific antigens and inhibitory receptors, to enhance precision and minimize off-target effects Exploring mechanisms to fine-tune T-cell engagement, such as conditional activation, dual-specificity designs, and regulatory T-cell recruitment Optimizing therapeutic strategies by leveraging insights from oncology, including biomarker-driven target selection and cytokine modulation approachesRead more
day: Day 1